S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RA Capital Management/Q2 2021

RA Capital Management

Periodo: Q2 2021 Β· Depositato: 2021-08-16
Vedi su SEC EDGAR β†—
AUM
$6.23B
Valore totale del portafoglio
Posizioni
92
Titoli dichiarati
Prima Posizione
ASND
14.4% $895.4M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-08-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ASNDASCENDIS PHARMA A/S$895.4M14.37%$131.55$274.50+108.7%
14.4%
NVAXNOVAVAX INC$543.5M8.72%$212.31$9.74-95.4%
8.7%
FMTXFORMA THERAPEUTICS HLDGS INC$224.3M3.60%β€”β€”
3.6%
JANXJANUX THERAPEUTICS INC$216.3M3.47%$24.95$15.54-37.7%
3.5%
VORXXXXVOR BIOPHARMA INC$207.4M3.33%β€”β€”
3.3%
AVTEAEROVATE THERAPEUTICS INC$188.7M3.03%β€”β€”
3.0%
NKTXNKARTA INC$177.6M2.85%$31.69$3.22-89.8%
2.9%
MGNXMACROGENICS INC$159.7M2.56%$26.86$4.71-82.5%
2.6%
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$136.5M2.19%β€”β€”
2.2%
TGTXTG THERAPEUTICS INC$129.7M2.08%$38.79$53.31+37.4%
2.1%
IMGNIMMUNOGEN INC$121.4M1.95%β€”β€”
1.9%
AVIRATEA PHARMACEUTICALS INC$115.3M1.85%$21.48$4.98-76.8%
1.9%
ITOSITEOS THERAPEUTICS INC$113.3M1.82%β€”β€”
1.8%
DAWNDAY ONE BIOPHARMACEUTICALS I$113.1M1.81%β€”β€”
1.8%
AXSMAXSOME THERAPEUTICS INC$111.7M1.79%$67.46$244.31+262.2%
1.8%
PHATPHATHOM PHARMACEUTICALS INC$105.4M1.69%$33.85$11.20-66.9%
1.7%
TILINSTIL BIO INC$94.1M1.51%$386.40$7.73-98.0%
1.5%
RCKTROCKET PHARMACEUTICALS INC COM$93.3M1.50%$44.29$3.84-91.3%
1.5%
ETNB89BIO INC$92.9M1.49%β€”β€”
1.5%
ZGNXZOGENIX INC$91.3M1.47%β€”β€”
1.5%
PCVXVAXCYTE INC$87.0M1.40%$22.51$58.39+159.4%
1.4%
KNTEKINNATE BIOPHARMA INC$83.7M1.34%β€”β€”
1.3%
GRPHGRAPHITE BIO INC$82.9M1.33%β€”β€”
1.3%
TVTXTRAVERE THERAPEUTICS INC$81.9M1.31%$14.59$56.92+290.1%
1.3%
HOWLWEREWOLF THERAPEUTICS INC$74.8M1.20%$17.44$0.34-98.0%
1.2%
RYTMRHYTHM PHARMACEUTICALS INC$71.1M1.14%$19.58$114.17+483.1%
1.1%
CYTTCYTEIR THERAPEUTICS INC$69.5M1.12%β€”β€”
1.1%
GHRSGH RESEARCH PLC$64.7M1.04%$21.73$27.01+24.3%
1.0%
OLMAOLEMA PHARMACEUTICALS INC$60.2M0.97%$27.98$12.64-54.8%
1.0%
DYNDYNE THERAPEUTICS INC$59.0M0.95%$21.04$23.07+9.7%
0.9%

AttivitΓ  Trimestre su Trimestre

Q2 2021 vs. Q1 2021

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
JANXJANUX THERAPEUTICS INC$216.3M-37.7%
AVTEAEROVATE THERAPEUTICS INC$188.7M
DAWNDAY ONE BIOPHARMACEUTICALS I$113.1M
GRPHGRAPHITE BIO INC$82.9M
HOWLWEREWOLF THERAPEUTICS INC$74.8M-98.0%
CYTTCYTEIR THERAPEUTICS INC$69.5M
GHRSGH RESEARCH PLC$64.7M+24.3%
VERVVERVE THERAPEUTICS INC$53.0M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ADVMADVERUM BIOTECHNOLOGIES INC$92.3M
IGMSIGM BIOSCIENCES INC$75.4M
CNSTCONSTELLATION PHARMCETICLS INC$52.4M
STROSUTRO BIOPHARMA INC$48.2M
RLAYRELAY THERAPEUTICS INC$34.6M
SNDXSYNDAX PHARMACEUTICALS INC$22.9M
PRQRPROQR THERAPEUTICS N V$14.0M
ARYAARYA SCIENCES ACQUISITION CO$13.4M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
KALVKALVISTA PHARMACEUTICALS INC$37.3M+451.5%
ACHLACHILLES THERAPEUTICS PLC$26.1M+261.1%
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$81.2M+133.7%
MCRBSERES THERAPEUTICS INC$-74.2M+38.2%
MGNXMACROGENICS INC$2.5M+20.5%-82.5%
ASNDASCENDIS PHARMA A/S$69.0M+6.1%+108.7%
ETNB89BIO INC$-19.3M+4.8%
ITOSITEOS THERAPEUTICS INC$-37.7M+0.0%

Ridotte (3)

TickerEmittenteNozionaleVar. AzioniDal Deposito
TGTXTG THERAPEUTICS INC$-93.8M-27.9%+37.4%
NVAXNOVAVAX INC$-0.8M-14.7%-95.4%
CCXICHEMOCENTRYX INC$-135.4M-1.7%
← Torna agli Hedge Fund